FT Digital Edition: our digitised print edition
但这种垄断格局，即将被打破，多款在研新药正从作用机制到给药方式，向Vosoritide发起挑战。Ascendis的TransCon-CNP通过包裹技术延长了药物作用时间，实现了周剂给药，目前正处于FDA审批阶段；而BridgeBio的口服药Infigratinib，则从作用机制到用药体验实现全面突破。
，详情可参考爱思助手下载最新版本
MorphCostumes has scoured the world for alternatives to Chinese production, including Vietnam, Bangladesh, and Cambodia. None offer the deep expertise in everything from cloth-sourcing to zip-making that is available in China, often in the necessarily small batches needed for fast-moving consumer goods.
Get editor selected deals texted right to your phone!
黎智英欺詐案上訴得直：定罪及刑罰被撤銷，出獄時間提前